Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial

Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Only a behind-the-scenes revision update was made: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to study content, endpoints, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:59:50.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Locations section added with Michigan and New York. Separate Michigan Locations and New York Locations subsections were removed, and the HHS Vulnerability Disclosure footer link was removed.
    Difference
    0.3%
    Check dated 2025-12-23T21:12:30.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The only change is a site revision update (v3.3.2 added, v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:47:35.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The notice about government funding and potential operating delays has been removed; this does not affect the core trial information such as eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:58:08.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The update shows only minor UI refinements with no changes to core study details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:57:18.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    Updated operating status notice and added version 3.2.0; removed the GI stromal tumor resource (from the Genetic and Rare Diseases Information Center) and the prior version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:21:25.000Z thumbnail image

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.